Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Becton, Dickinson and Company (BDX) stock declined over -1.54% intraday to trade at $247.93 a share on NYSE. The stock opened with a gain of 0.58% at $248.92 and touched an intraday high of $250.405, falling -1.54% against the last close of $251.8. The stock went to a low of $243.81 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-05 | $248.92 | $250.405 | $243.81 | $247.93 | 654,527 |
2022-07-01 | $246.5 | $252.17 | $244.32 | $251.8 | 774,900 |
2022-06-30 | $248 | $249.66 | $245.48 | $246.53 | 1,403,100 |
2022-06-29 | $244.58 | $251.17 | $243.66 | $249.34 | 1,144,700 |
2022-06-28 | $250.53 | $251.7 | $244.39 | $244.53 | 873,800 |
2022-06-27 | $250.69 | $251.15 | $247.41 | $250.1 | 765,700 |
2022-06-24 | $246.57 | $251.26 | $243.23 | $250.92 | 1,555,400 |
2022-06-23 | $238.01 | $242.76 | $238.01 | $242.54 | 721,400 |
2022-06-22 | $235.64 | $239.13 | $234.03 | $237.27 | 1,395,900 |
2022-06-21 | $238 | $238 | $234.51 | $236.53 | 1,344,900 |
Employees-
Beta0.63
Sales or Revenue19.93 Billion
5Y Sales Change10.20%
Fiscal Year Ends2021-09-29
SectorHealth Care
IndustryHealth Care Equipment
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Becton, Dickinson and Company (NYSE: BDX) stock price is $247.93 as of the last check on Tuesday, July 5. During the trading session, BDX stock reached the peak price of $250.405 while $243.81 was the lowest point it dropped to.
The NYSE listed BDX is part of Health Care Equipment industry that operates in the broader Health Care sector. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.
Mr. Thomas E. Polen Jr.
Pres, CEO & Chairman
Mr. Christopher DelOrefice
Exec. VP & CFO
Mr. Samrat S. Khichi Esq.
Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
Mr. Alberto Mas
Exec. VP & Pres of the Medical Segment
BDX stock traded closed the last session at $247.93, which is $-3.87 or -1.54% lower than its previous close of $251.8. BDX's current trading price is 8.15% lower than its 52-week high of $277.29 where as its distance from 52-week low of 229.24% is -10.59%.
Number of BDX employees currently stands at -. BDX operates from 1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States.
Official Webiste of $BDX is: https://www.bd.com
BDX could be contacted at BDX operates from 1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States, or at phone #201 847 6800 and can also be accessed through its website.
BDX stock volume for the day was 776,563 shares while in the previous session number of BDX shares traded was 654,527 . The average number of BDX shares traded daily for last 3 months was 1.15 Million.
The percentage change in BDX stock occurred in the recent session was -1.54% while the dollar amount for the price change in BDX stock was $-3.87.
In the recent session, the day high for BDX stock was $250.405 while the low for BDX stock touched on the day was $243.81.
The market value of BDX currently stands at 69.2 Billion with its latest stock price at $247.93 and 285.24 Million of its shares outstanding.